Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.7B | 4.8B | 4.6B | 4.5B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.8B | 1.7B | 1.7B | 1.7B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 1.5B | 1.5B | 1.5B | 1.5B |
Tax provision | 300M | 315M | 336M | 357M |
Net income | 1.2B | 1.2B | 1.2B | 1.2B |
Basic EPS | 1.6 | 1.6 | 1.5 | 1.5 |
Diluted EPS | 1.6 | 1.5 | 1.5 | 1.5 |
Basic average shares | 721.0M | 726.6M | 736.5M | 746.9M |
Diluted average shares | 727.4M | 733.7M | 742.1M | 751.6M |
EBITDA | — | — | — | — |
Net income from continuing op. | 1.2B | 1.2B | 1.2B | 1.2B |
Minority interests | -2M | -2M | -7M | -2M |
Preferred stock dividends | — | — | — | — |